These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 38476596)

  • 1. Editorial: Multipurpose prevention technologies for HIV, STIs and pregnancies.
    Friedland BA; Thurman AR; Nuwagaba-Biribonwoha H; Malcolm RK
    Front Reprod Health; 2024; 6():1384153. PubMed ID: 38476596
    [No Abstract]   [Full Text] [Related]  

  • 2. Optimizing the pipeline of multipurpose prevention technologies: opportunities across women's reproductive lifespans.
    Bershteyn A; Resar D; Kim HY; Platais I; Mullick S
    Front Reprod Health; 2023; 5():1169110. PubMed ID: 37325241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interest in multipurpose prevention technologies to prevent HIV/STIs and unintended pregnancy among young women in the United States.
    Hynes JS; Sales JM; Sheth AN; Lathrop E; Haddad LB
    Contraception; 2018 Mar; 97(3):277-284. PubMed ID: 29055782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multipurpose prevention technologies: products in development.
    Friend DR; Clark JT; Kiser PF; Clark MR
    Antiviral Res; 2013 Dec; 100 Suppl():S39-47. PubMed ID: 24188708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Turning the promise of multipurpose prevention technologies into a market reality: a commentary.
    Dam A; Schueller J; Peine KJ; Mason J; Dorward E; Vij A
    Front Reprod Health; 2023; 5():1181043. PubMed ID: 38023534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in long-acting injectables, implants, and vaginal rings for contraception and HIV prevention.
    Krovi SA; Johnson LM; Luecke E; Achilles SL; van der Straten A
    Adv Drug Deliv Rev; 2021 Sep; 176():113849. PubMed ID: 34186143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lessons from reproductive health to inform multipurpose prevention technologies: don't reinvent the wheel.
    Brady M; Manning J
    Antiviral Res; 2013 Dec; 100 Suppl():S25-31. PubMed ID: 24188700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preferences, educational messaging, and demand creation channels for multipurpose-prevention technologies (MPTs) among women in South Africa.
    Mataboge P; Mthimkhulu N; Kutywayo A; Martin CE; Mazibuko M; Kwatsha K; Makalela N; Briedenhann E; Butler V; Bothma R; Mullick S
    BMC Public Health; 2023 Oct; 23(1):2090. PubMed ID: 37880628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strategic actions to advance multipurpose prevention technologies in low- and middle-income countries.
    Young Holt B; van der Straten A; Barker T; Chirenje ZM; Cameron AI; Scott C; Casas CP; Romano J
    Front Reprod Health; 2023; 5():1150857. PubMed ID: 37465533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multipurpose Prevention Technologies: Oral, Parenteral, and Vaginal Dosage Forms for Prevention of HIV/STIs and Unplanned Pregnancy.
    Young IC; Benhabbour SR
    Polymers (Basel); 2021 Jul; 13(15):. PubMed ID: 34372059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multipurpose prevention technologies for sexual and reproductive health: mapping global needs for introduction of new preventive products.
    Schelar E; Polis CB; Essam T; Looker KJ; Bruni L; Chrisman CJ; Manning J
    Contraception; 2016 Jan; 93(1):32-43. PubMed ID: 26385588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging Technologies to Prevent Pregnancy and Sexually Transmitted Infections in Women.
    Seidman D; Hemmerling A; Smith-McCune K
    Semin Reprod Med; 2016 May; 34(3):159-67. PubMed ID: 26956691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expanding the pipeline for multipurpose prevention technologies: compounds with potential activity to prevent or treat HIV and other STIs.
    Young Holt B; Hemmerling A; Moore S; Yang K
    Sex Transm Infect; 2023 May; 99(3):203-207. PubMed ID: 36878691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preferred Product Attributes of Potential Multipurpose Prevention Technologies for Unintended Pregnancy and Sexually Transmitted Infections or HIV Among U.S. Women.
    Hynes JS; Sheth AN; Lathrop E; Sales JM; Haddad LB
    J Womens Health (Larchmt); 2019 May; 28(5):665-672. PubMed ID: 30615569
    [No Abstract]   [Full Text] [Related]  

  • 15. Multipurpose prevention technologies for reproductive and sexual health.
    Stone A
    Reprod Health Matters; 2014 Nov; 22(44):213-7. PubMed ID: 25555778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sexual behaviour and incidence of HIV and sexually transmitted infections among men who have sex with men using daily and event-driven pre-exposure prophylaxis in AMPrEP: 2 year results from a demonstration study.
    Hoornenborg E; Coyer L; Achterbergh RCA; Matser A; Schim van der Loeff MF; Boyd A; van Duijnhoven YTHP; Bruisten S; Oostvogel P; Davidovich U; Hogewoning A; Prins M; de Vries HJC;
    Lancet HIV; 2019 Jul; 6(7):e447-e455. PubMed ID: 31178284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. End-to-end approach to ensuring equitable access to multipurpose prevention technologies in low- and middle-income countries.
    Cameron AI; Scott C; Pérez-Casas C; Barker T
    Front Reprod Health; 2023; 5():1238813. PubMed ID: 37711397
    [No Abstract]   [Full Text] [Related]  

  • 18. Multipurpose prevention technologies: the future of HIV and STI protection.
    Fernández-Romero JA; Deal C; Herold BC; Schiller J; Patton D; Zydowsky T; Romano J; Petro CD; Narasimhan M
    Trends Microbiol; 2015 Jul; 23(7):429-436. PubMed ID: 25759332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Equipping providers to offer novel MPTs: Developing counseling messages for the Dual Prevention Pill in clinical studies and beyond.
    Segal K; Harris DM; Carmone A; Haddad LB; Hadigal S; Hatzold K; Jones C; Lathrop E; Mason J; Mikulich M
    Front Reprod Health; 2023; 5():1155948. PubMed ID: 37284490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relationship between HIV pre-exposure prophylaxis, sexually transmitted infections, and antimicrobial resistance: a qualitative interview study of men who have sex with men.
    Williams ADN; Wood F; Gillespie D; Couzens Z; Hughes K; Hood K
    BMC Public Health; 2022 Nov; 22(1):2222. PubMed ID: 36447181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.